Prolonged Viability of Human Skin Xenografts in Rats by Cyclosporine**Presented in part at the Annual Meeting of The Society for Investigative Dermatology, Inc., Washington, D.C., May 7–9, 1984.
- 1 June 1986
- journal article
- research article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 86 (6) , 611-614
- https://doi.org/10.1111/1523-1747.ep12275576
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Growth pattern of tumor xenografts in wistar rats after treatment with cyclophosphamide, total lymphoid irradiation and/or cyclosporin AInternational Journal of Radiation Oncology*Biology*Physics, 1983
- IMMUNOBIOLOGY OF CYCLOSPORIN A—A REVIEWImmunology & Cell Biology, 1983
- Role of Antibody to S100 Protein in Diagnostic PathologyAmerican Journal of Clinical Pathology, 1983
- CYCLOSPORIN-A INHIBITS LYMPHOKINE PRODUCTION BUT NOT THE RESPONSES OF MACROPHAGES TO LYMPHOKINES1983
- CYCLOSPORIN A PREVENTS THE APPEARANCE OF CELL SURFACE “ACTIVATION” ANTIGENSTransplantation, 1982
- Cyclosporin A blocks receptors for HLA-DR antigens on T cellsNature, 1981
- Effect of Lipid-Soluble Esters of Methotrexate on dna Synthesis in Human Skin**From the Department of Dermatology, University of Miami School of Medicine, Miami, Florida. (Reprint requests to: Department of Dermatology, University of Miami School of Medicine, P. O. Box 520875, Biscayne Annex, Miami, Florida 33152.)Journal of Investigative Dermatology, 1974